84 related articles for article (PubMed ID: 21591320)
1. [Hawthorn extract WS 1442 in the treatment of patients with heart failure and LVEF of 25%-35%].
Von Holubarsch CJ; Niestroj M; Wassmer A; Gaus W; Meinertz T
MMW Fortschr Med; 2010 Jul; 152 Suppl 2():56-61. PubMed ID: 21591320
[No Abstract] [Full Text] [Related]
2. The efficacy and safety of Crataegus extract WS 1442 in patients with heart failure: the SPICE trial.
Holubarsch CJ; Colucci WS; Meinertz T; Gaus W; Tendera M;
Eur J Heart Fail; 2008 Dec; 10(12):1255-63. PubMed ID: 19019730
[TBL] [Abstract][Full Text] [Related]
3. [Decreased cardiac output in the elderly. Cardiotonic effect of hawthorn].
MMW Fortschr Med; 2012 Dec; 154(22):64-5. PubMed ID: 23297544
[No Abstract] [Full Text] [Related]
4. Health effects of hawthorn.
Dahmer S; Scott E
Am Fam Physician; 2010 Feb; 81(4):465-8. PubMed ID: 20148500
[TBL] [Abstract][Full Text] [Related]
5. [Oligomeric procyanidins from hawthorn extract as supplementary therapy in patients with left ventricle systolic dysfunction].
Rechciński T; Kurpesa M
Przegl Lek; 2005; 62(4):243-4. PubMed ID: 16229244
[TBL] [Abstract][Full Text] [Related]
6. [Even in advanced heart failure, hawthorn improves physical capacity].
MMW Fortschr Med; 2003 Jan; 145(1-2):52. PubMed ID: 12638441
[No Abstract] [Full Text] [Related]
7. ACC/AHA guideline update: treatment of heart failure with reduced left ventricular ejection fraction.
Aronow WS
Geriatrics; 2006 Mar; 61(3):22-9. PubMed ID: 16522132
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study.
Cleland JG; Louis AA; Rigby AS; Janssens U; Balk AH;
J Am Coll Cardiol; 2005 May; 45(10):1654-64. PubMed ID: 15893183
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of T-wave alternans in patients with heart failure due to nonischemic cardiomyopathy: results of the ALPHA Study.
Salerno-Uriarte JA; De Ferrari GM; Klersy C; Pedretti RF; Tritto M; Sallusti L; Libero L; Pettinati G; Molon G; Curnis A; Occhetta E; Morandi F; Ferrero P; Accardi F;
J Am Coll Cardiol; 2007 Nov; 50(19):1896-904. PubMed ID: 17980258
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
11. Prospective, comparative cohort studies and their contribution to the benefit assessments of therapeutic options: heart failure treatment with and without Hawthorn special extract WS 1442.
Habs M
Forsch Komplementarmed Klass Naturheilkd; 2004 Aug; 11 Suppl 1():36-9. PubMed ID: 15353901
[TBL] [Abstract][Full Text] [Related]
12. Inotropic therapy: an important role in the treatment of advanced symptomatic heart failure.
McCann P; Hauptman PJ
Med Clin North Am; 2012 Sep; 96(5):943-54. PubMed ID: 22980057
[TBL] [Abstract][Full Text] [Related]
13. Benefit-Risk Assessment of Crataegus Extract WS 1442: An Evidence-Based Review.
Holubarsch CJF; Colucci WS; Eha J
Am J Cardiovasc Drugs; 2018 Feb; 18(1):25-36. PubMed ID: 29080984
[TBL] [Abstract][Full Text] [Related]
14. Heart attack patients with complications. Treat with valsartan, captopril, or both?
Nguyen A; Sharma S
Can Fam Physician; 2004 Aug; 50():1093-5. PubMed ID: 15455807
[No Abstract] [Full Text] [Related]
15. Clinical efficacy of crataegus extract WS 1442 in congestive heart failure NYHA class II.
Zapfe jun G
Phytomedicine; 2001 Jul; 8(4):262-6. PubMed ID: 11515715
[TBL] [Abstract][Full Text] [Related]
16. Treatment practices in heart failure with preserved left ventricular ejection fraction: a prospective observational study.
Peltier M; Houpe D; Cohen-Solal A; Béguin M; Levy F; Tribouilloy C
Int J Cardiol; 2007 Jun; 118(3):363-9. PubMed ID: 17049391
[TBL] [Abstract][Full Text] [Related]
17. [Hawthorn slows blood vessel aging].
Red
MMW Fortschr Med; 2016 Apr; 158(8):87. PubMed ID: 27116177
[No Abstract] [Full Text] [Related]
18. [Differences in clinical profile and outcome in patients with decompensated heart failure and systolic dysfunction or preserved systolic function].
Macín SM; Perna ER; Címbaro Canella JP; Alvarenga P; Pantich R; Ríos N; Farías EF; Badaracco JR
Rev Esp Cardiol; 2004 Jan; 57(1):45-52. PubMed ID: 14746717
[TBL] [Abstract][Full Text] [Related]
19. Hawthorn extract improves chronic heart failure.
Eaton LJ; Kinkade S
J Fam Pract; 2003 Oct; 52(10):753-4. PubMed ID: 14529593
[No Abstract] [Full Text] [Related]
20. The importance of heart rate recovery in patients with heart failure or left ventricular systolic dysfunction.
Lipinski MJ; Vetrovec GW; Gorelik D; Froelicher VF
J Card Fail; 2005 Oct; 11(8):624-30. PubMed ID: 16230267
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
